Delivery Order HHSN275201300025I-HHSN27500003

Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center is delivering a 28 Day Study under a $2,099,607.44 potential value task order against the National Institutes of Health National Institute of Child Health and Human Development's Contraceptive Clinical Trials Network indefinite delivery contract. The contract has no set-aside designation. As the prime contractor, Lundquist Institute will conduct this clinical trial through December 31, 2021 to evaluate male contraceptive...

This is a delivery order contract awarded by the National Institute of Child Health and Human Development (NICHD) to the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, a non-profit research organization. The contract, with a ceiling value of $2,795,103, is part of the NICHD Contraceptive Clinical Trials Network and supports the Male Contraceptive Trials topic area. The work involves evaluating products that have undergone successful preclinical testing for the...

This is a $336,724 cost-no-fee delivery order awarded by the National Institute of Child Health and Human Development (NICHD) to the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, a non-profit research organization. The order was placed under a larger $10 million indefinite delivery contract for the NICHD Contraceptive Clinical Trials Networks - Male Studies program, which supports core functions related to male contraceptive clinical trials over a 7-year period....

The National Institutes of Health's National Institute of Child Health and Human Development awarded New York University School of Medicine a $687,579 delivery order under the Contraceptive Clinical Trials Network - Clinical Evaluation of Novel Products for Female Contraception: Efficacy Study indefinite delivery contract. The award supports NYU's work conducting clinical trials and efficacy studies for novel female contraceptive products to advance the agency's mission of women's reproductive...

This is a delivery order under the National Institute of Child Health and Human Development (NICHD) Contraceptive Clinical Trials Network IDIQ contract, awarded to the University of Washington (UW) on January 30, 2014. The $2,251,734.38 firm fixed price contract is for a DMAU-SEDDS STUDY, to be completed by November 30, 2024. The award has no set-aside designation. As a leading research university, UW has a history of prime federal contract and grant awards, including work for the Department...

The U.S. National Institute of Child Health and Human Development (NICHD) has awarded a $994,099 delivery order contract to Health Decisions, Inc., a for-profit clinical research organization, to provide a range of services related to clinical trials evaluating progestogenic androgens as contraceptive agents. The contract covers activities such as protocol finalization, start-up, coordination, monitoring, and other associated tasks for these clinical trials. This delivery order is part of a...

The National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $176,019 delivery order to the Albert Einstein College of Medicine, a private non-profit educational institution, to perform services related to the Ovaprene Vaginal Device clinical trial. The contract, which has no set-aside designation, covers protocol finalization, regulatory approval, start-up, and commencement of recruitment,...

This federal contract award is a delivery order with a ceiling value of $1,122,160.42, issued by the National Institute of Child Health and Human Development (NICHD) to Eastern Virginia Medical School (EVMS) to conduct a multi-center, randomized study evaluating the pharmacokinetic and pharmacodynamic profile, contraceptive efficacy, and safety of daily oral low dose ulipristal acetate. The contract is part of NICHD's Contraceptive Clinical Trials Network program, which supports research to...

This federal contract award is a delivery order issued under the "THE STATISTICAL AND CLINICAL COORDINATING CENTER IDIQ" contract, which was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency. The contract is for R&D support for a Phase IIb clinical trial of subcutaneous levonorgestrel butanoate (LB) for female contraception. The contract is non-severable and has a ceiling value of $2,355,840.00. The prime contractor is Health...

This federal contract award was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to the Magee-Womens Research Institute and Foundation, a non-profit research organization. The $1,585,279 delivery order contract is for a randomized controlled clinical trial to evaluate the efficacy, safety, and acceptability of the C31G female contraceptive. The contract has no set-aside designation and was...